These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32402060)

  • 1. Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial.
    Doehner W; Gerstein HC; Ried J; Jung H; Asbrand C; Hess S; Anker SD
    Eur Heart J; 2020 Jul; 41(28):2668-2677. PubMed ID: 32402060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
    Pagidipati NJ; Zheng Y; Green JB; McGuire DK; Mentz RJ; Shah S; Aschner P; Delibasi T; Rodbard HW; Westerhout CM; Holman RR; Peterson ED;
    Am Heart J; 2020 Jan; 219():47-57. PubMed ID: 31707324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population.
    Doehner W; Erdmann E; Cairns R; Clark AL; Dormandy JA; Ferrannini E; Anker SD
    Int J Cardiol; 2012 Dec; 162(1):20-6. PubMed ID: 22037349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.
    Papademetriou V; Nylen ES; Doumas M; Probstfield J; Mann JFE; Gilbert RE; Gerstein HC
    Am J Med; 2017 Dec; 130(12):1465.e27-1465.e39. PubMed ID: 28842165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials.
    Marsico F; Paolillo S; Gargiulo P; Bruzzese D; Dell'Aversana S; Esposito I; Renga F; Esposito L; Marciano C; Dellegrottaglie S; Iesu I; Perrone Filardi P
    Eur Heart J; 2020 Sep; 41(35):3346-3358. PubMed ID: 32077924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint association of body mass index and central obesity with cardiovascular events and all-cause mortality in prediabetic population: A prospective cohort study.
    Liu L; Gao B; Wang J; Yang C; Wu S; Wu Y; Chen S; Li Q; Zhang H; Wang G; Chen M; Pop-Busui R; Zhao MH; Zhang L
    Obes Res Clin Pract; 2019; 13(5):453-461. PubMed ID: 31558371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight change is associated with increased all-cause mortality and non-cardiac mortality among patients with type 2 diabetes mellitus.
    Xing Z; Pei J; Huang J; Peng X; Chen P; Hu X; Gao S
    Endocrine; 2019 Apr; 64(1):82-89. PubMed ID: 30864142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?
    Prausmüller S; Weidenhammer A; Heitzinger G; Spinka G; Goliasch G; Arfsten H; Abdel Mawgoud R; Gabler C; Strunk G; Hengstenberg C; Hülsmann M; Bartko PE; Pavo N
    Eur J Prev Cardiol; 2023 Sep; 30(12):1247-1254. PubMed ID: 37210596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of diabesity with all-cause and cardiovascular disease mortality: Findings from the Mexico City Prospective Study.
    Petermann-Rocha F; Apolinar E; Nazar G; Diaz-Toro F; Celis A; Deo S; Ferrari G; O'Donovan G
    Diabetes Obes Metab; 2024 Jun; 26(6):2199-2208. PubMed ID: 38439662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial.
    Doehner W; Schenkel J; Anker SD; Springer J; Audebert HJ
    Eur Heart J; 2013 Jan; 34(4):268-77. PubMed ID: 23076781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits.
    Liakopoulos V; Franzén S; Svensson AM; Sattar N; Miftaraj M; Björck S; Ottosson J; Näslund I; Gudbjörnsdottir S; Eliasson B
    Diabetes Care; 2020 Jun; 43(6):1276-1284. PubMed ID: 32152136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China.
    Lyu SQ; Yang YM; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Ren JM
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2242-2251. PubMed ID: 32900569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence and temporality of the obesity paradox in coronary bypass surgery: an analysis of cause-specific mortality.
    Schwann TA; Ramia PS; Engoren MC; Bonnell MR; Goodwin M; Monroe I; Habib RH
    Eur J Cardiothorac Surg; 2018 Nov; 54(5):896-903. PubMed ID: 29868854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: over a decade of follow-up in the Tehran Lipid and Glucose Study.
    Deravi N; Moazzeni SS; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
    BMC Public Health; 2022 Sep; 22(1):1762. PubMed ID: 36114528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus.
    Salehidoost R; Mansouri A; Amini M; Yamini SA; Aminorroaya A
    Acta Diabetol; 2018 Jun; 55(6):569-577. PubMed ID: 29546575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
    Wannamethee SG; Shaper AG; Walker M
    J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of overweight on clinical outcomes in patients undergoing coronary revascularization].
    Kang JP; Ma CS; Lü Q; Nie SP; Liu XM; Liu XH; DU X; Hu R; Dong JZ; Chen F; Lü SZ; Gu CX; Huang FJ; Wu XS
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1381-4. PubMed ID: 20646625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined associations of body mass index and adherence to a Mediterranean-like diet with all-cause and cardiovascular mortality: A cohort study.
    Michaëlsson K; Baron JA; Byberg L; Höijer J; Larsson SC; Svennblad B; Melhus H; Wolk A; Warensjö Lemming E
    PLoS Med; 2020 Sep; 17(9):e1003331. PubMed ID: 32941436
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.